Literature DB >> 18621146

How many modes of action should an antibiotic have?

Heike Brötz-Oesterhelt1, Nina A Brunner.   

Abstract

All antibiotics that have been successfully employed for decades as monotherapeutics in the treatment of bacterial infections rely on mechanisms of bacterial growth inhibition which are by far more complex than inhibition of a single enzyme. Such successful antibiotics have in common that they address several targets in parallel and/or that their targets are encoded by multiple genes. Such multiplicity of targets and of target genes has the advantage that the emergence of spontaneous target-related resistance is a comparatively slow process. Recently registered antibiotics and novel antibiotics in development are discussed in the light of this promising concept of antibacterial polypharmacology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621146     DOI: 10.1016/j.coph.2008.06.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  31 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 2.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

4.  Structural analysis of a 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase with an N-terminal chorismate mutase-like regulatory domain.

Authors:  Samuel H Light; Andrei S Halavaty; George Minasov; Ludmilla Shuvalova; Wayne F Anderson
Journal:  Protein Sci       Date:  2012-04-23       Impact factor: 6.725

Review 5.  Appropriate Targets for Antibacterial Drugs.

Authors:  Lynn L Silver
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

6.  Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.

Authors:  Anna Müller; Daniela Münch; Yvonne Schmidt; Katrin Reder-Christ; Guido Schiffer; Gerd Bendas; Harald Gross; Hans-Georg Sahl; Tanja Schneider; Heike Brötz-Oesterhelt
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

7.  Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.

Authors:  Michaela Wenzel; Bastian Kohl; Daniela Münch; Nadja Raatschen; H Bauke Albada; Leendert Hamoen; Nils Metzler-Nolte; Hans-Georg Sahl; Julia E Bandow
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

8.  Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45.

Authors:  Yoshimasa Ishizaki; Chigusa Hayashi; Kunio Inoue; Masayuki Igarashi; Yoshiaki Takahashi; Venugopal Pujari; Dean C Crick; Patrick J Brennan; Akio Nomoto
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

9.  Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli.

Authors:  Byung Jo Yu; Jung Ae Kim; Hyun Mok Ju; Soo-Kyung Choi; Seung Jin Hwang; Sungyoo Park; Euijoong Kim; Jae-Gu Pan
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

Review 10.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.